Bharat [BIBCL] vs Biocon [BIOCON] Detailed Stock Comparison
Bharat
BSE
Loading...
Biocon
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Bharat wins in 3 metrics, Biocon wins in 14 metrics, with 0 ties. Biocon appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bharat | Biocon | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -5.48 | 109.74 | Bharat |
| Price-to-Book Ratio | 1.16 | 1.95 | Bharat |
| Debt-to-Equity Ratio | 94.48 | 66.26 | Biocon |
| PEG Ratio | -0.09 | -1.15 | Biocon |
| EV/EBITDA | -7.87 | 19.24 | Bharat |
| Profit Margin (TTM) | -241.59% | 2.44% | Biocon |
| Operating Margin (TTM) | -2,888.44% | 7.46% | Biocon |
| EBITDA Margin (TTM) | N/A | 7.46% | N/A |
| Return on Equity | -21.00% | 3.66% | Biocon |
| Return on Assets (TTM) | -6.28% | 1.72% | Biocon |
| Free Cash Flow (TTM) | $108.92M | $17.18B | Biocon |
| Dividend Yield | N/A | 0.26% | N/A |
| 1-Year Return | -21.99% | 0.46% | Biocon |
| Price-to-Sales Ratio (TTM) | 11.76 | 2.98 | Biocon |
| Enterprise Value | $1.56B | $620.67B | Biocon |
| EV/Revenue Ratio | 20.45 | 3.94 | Biocon |
| Gross Profit Margin (TTM) | N/A | 64.06% | N/A |
| Revenue per Share (TTM) | $2 | $131 | Biocon |
| Earnings per Share (Diluted) | $-4.18 | $3.21 | Biocon |
| Beta (Stock Volatility) | 0.91 | 0.25 | Biocon |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Bharat vs Biocon Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bharat | 0.28% | -1.73% | -4.53% | -11.28% | -1.73% | -13.82% |
| Biocon | 0.01% | 2.23% | -4.50% | -6.54% | 13.09% | -5.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bharat | -21.99% | -13.47% | -4.44% | -27.59% | 5.61% | -10.34% |
| Biocon | 0.46% | 33.08% | -22.36% | 362.62% | 421.60% | 745.08% |
News Based Sentiment: Bharat vs Biocon
Bharat
News based Sentiment: MIXED
The month's developments present a mixed picture for Bharat Immunologicals & Biologicals Corporation. While the share price showed a slight increase and the company continues to diversify its product line, the overall year-long decline and price volatility create uncertainty for investors.
Biocon
News based Sentiment: MIXED
October presented a mixed picture for Biocon, with positive developments like US market entry for biosimilars and Rifaximin tablets offset by weaker-than-expected financial results and a high valuation. The company is making strategic moves, but profitability remains a key concern for investors.
Performance & Financial Health Analysis: Bharat vs Biocon
| Metric | BIBCL | BIOCON |
|---|---|---|
| Market Information | ||
| Market Cap | ₹910.67M | ₹470.24B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 16,386 | 1,896,179 |
| 90 Day Avg. Volume | 25,808 | 2,533,957 |
| Last Close | ₹21.13 | ₹347.80 |
| 52 Week Range | ₹19.00 - ₹35.88 | ₹291.00 - ₹406.00 |
| % from 52W High | -41.11% | -14.33% |
| All-Time High | ₹94.50 (Jun 14, 2021) | ₹487.75 (Dec 21, 2020) |
| % from All-Time High | -77.64% | -28.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.99% | 0.15% |
| Quarterly Earnings Growth | -1.00% | -0.95% |
| Financial Health | ||
| Profit Margin (TTM) | -2.42% | 0.02% |
| Operating Margin (TTM) | -28.88% | 0.07% |
| Return on Equity (TTM) | -0.21% | 0.04% |
| Debt to Equity (MRQ) | 94.48 | 66.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹18.24 | ₹180.66 |
| Cash per Share (MRQ) | ₹2.07 | ₹38.10 |
| Operating Cash Flow (TTM) | ₹87.48M | ₹17.78B |
| Levered Free Cash Flow (TTM) | ₹-166,388,000 | ₹10.13B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.26% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Bharat vs Biocon
| Metric | BIBCL | BIOCON |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -5.48 | 109.74 |
| Forward P/E | N/A | 35.51 |
| PEG Ratio | -0.09 | -1.15 |
| Price to Sales (TTM) | 11.76 | 2.98 |
| Price to Book (MRQ) | 1.16 | 1.95 |
| Market Capitalization | ||
| Market Capitalization | ₹910.67M | ₹470.24B |
| Enterprise Value | ₹1.56B | ₹620.67B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 20.45 | 3.94 |
| Enterprise to EBITDA | -7.87 | 19.24 |
| Risk & Other Metrics | ||
| Beta | 0.91 | 0.25 |
| Book Value per Share (MRQ) | ₹18.24 | ₹180.66 |
Financial Statements Comparison: Bharat vs Biocon
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BIBCL | BIOCON |
|---|---|---|
| Revenue/Sales | ₹0 | ₹39.10B |
| Cost of Goods Sold | ₹0 | ₹14.05B |
| Gross Profit | ₹0 | ₹25.05B |
| Research & Development | N/A | ₹-346.00M |
| Operating Income (EBIT) | ₹-47.23M | ₹2.94B |
| EBITDA | ₹-45.25M | ₹8.29B |
| Pre-Tax Income | ₹-66.46M | ₹969.00M |
| Income Tax | ₹-17.28M | ₹77.00M |
| Net Income (Profit) | ₹-49.18M | ₹892.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BIBCL | BIOCON |
|---|---|---|
| Cash & Equivalents | ₹14.58M | ₹32.27B |
| Total Current Assets | ₹327.10M | ₹162.86B |
| Total Current Liabilities | ₹990.55M | ₹143.34B |
| Long-Term Debt | ₹35.00M | ₹129.45B |
| Total Shareholders Equity | ₹787.09M | ₹277.13B |
| Retained Earnings | N/A | ₹189.59B |
| Property, Plant & Equipment | N/A | ₹4.32B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BIBCL | BIOCON |
|---|---|---|
| Operating Cash Flow | ₹-708.65M | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | ₹-456.88M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BIBCL | BIOCON |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 16,386 | 1,896,179 |
| Average Daily Volume (90 Day) | 25,808 | 2,533,957 |
| Shares Outstanding | 43.18M | 1.20B |
| Float Shares | 17.58M | 524.74M |
| % Held by Insiders | 0.59% | 0.55% |
| % Held by Institutions | 0.00% | 0.24% |
Dividend Analysis & Yield Comparison: Bharat vs Biocon
| Metric | BIBCL | BIOCON |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.26% |
| 3-Year Avg Annual Dividend | N/A | ₹1.33 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | ₹4.00 |
| Ex-Dividend Date | N/A | Jul 04, 2025 |